Uncovering the significance of CBX3 as an up-and-coming biomarker in cardio-vascular health
Muhammad Aamir Wahab(University of Campania "Luigi Vanvitelli"), Mariarosaria Conte(University of Campania "Luigi Vanvitelli"), Lucia Altucci(Biogem), Vincenzo Quagliariello(Cancer Institute (WIA)), Nicola Maurea(Cancer Institute (WIA)), Nunzio Del Gaudio(University of Campania "Luigi Vanvitelli"), Michèle Grieco(Collaborative Group (United States)), Rosaria Benedetti(University of Campania "Luigi Vanvitelli"), Biagio Gargiulo(University of Campania "Luigi Vanvitelli"), Angela Nebbioso(University of Campania "Luigi Vanvitelli")
Cited by 1
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116